Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Science Immunology|October 4, 2024
Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicryYi Zhou, Yaxin Zhang, Mingzhou Li, et al.Journal of Experimental & Clinical Cancer Research : CR|September 29, 2021
Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRCChengmei Huang, Ruizhang Ou, Xiaoning Chen, et al.Cancer Discovery|April 29, 2020
Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic CancerPingping Hou, Avnish Kapoor, Qiang Zhang, et al.Developmental Cell|October 28, 2021
A bipartite element with allele-specific functions safeguards DNA methylation imprints at the Dlk1-Dio3 locusBoaz E Aronson, Laurianne Scourzic, Veevek Shah, et al.Nature Aging|January 17, 2022
Telomerase Reverse Transcriptase Preserves Neuron Survival and Cognition in Alzheimer's Disease ModelsHong Seok Shim, James W Horner, Chang-Jiun Wu, et al.Developmental Cell|April 4, 2024
Telomere dysfunction alters intestinal stem cell dynamics to promote cancerKyle A LaBella, Wen-Hao Hsu, Jiexi Li, et al.Cancer Discovery|May 10, 2020
Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate CancerDi Zhao, Li Cai, Xin Lu, et al.Nature|June 21, 2023
Histone demethylase KDM5D upregulation drives sex differences in colon cancerJiexi Li, Zhengdao Lan, Wenting Liao, et al.Cancer Cell|March 26, 2019
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal CancerWenting Liao, Michael J Overman, Adam T Boutin, et al.Nature Communications|September 22, 2020
Telomere dysfunction activates YAP1 to drive tissue inflammationDeepavali Chakravarti, Baoli Hu, Xizeng Mao, et al.Pageof 2